Monastrol (b)

CAS No. 329689-23-8

Monastrol (b)( ±)-Monastrol )

Catalog No. M14088 CAS No. 329689-23-8

A potent, specific, allosteric and reversible mitotic kinesin Eg5 inhibitor with IC50 of 14 uM (microtubule motility inhibition).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 50 In Stock
5MG 61 In Stock
10MG 84 In Stock
25MG 171 In Stock
50MG 288 In Stock
100MG 514 In Stock
500MG 1125 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Monastrol (b)
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent, specific, allosteric and reversible mitotic kinesin Eg5 inhibitor with IC50 of 14 uM (microtubule motility inhibition).
  • Description
    A potent, specific, allosteric and reversible mitotic kinesin Eg5 inhibitor with IC50 of 14 uM (microtubule motility inhibition); does not inhibit microtubule motility driven by conventional kinesin at 200 uM; inhibits both the basal and the microtubule-stimulated ATPase activity of the Eg5 motor domain, does not compete with ATP binding to Eg5; arrests cells in mitosis with monoastral spindles, and (S)-monastrol is a more potent inhibitor of Eg5 activity in vitro and in vivo.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ±)-Monastrol
  • Pathway
    Cytoskeleton/Cell Adhesion Molecules
  • Target
    Kinesin
  • Recptor
    Eg5
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    329689-23-8
  • Formula Weight
    292.35344
  • Molecular Formula
    C14H16N2O3S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: ≥ 33 mg/mL
  • SMILES
    CCOC(=O)C1=C(NC(=S)NC1C2=CC(=CC=C2)O)C
  • Chemical Name
    5-Pyrimidinecarboxylic acid, 1,2,3,4-tetrahydro-4-(3-hydroxyphenyl)-6-methyl-2-thioxo-, ethyl ester

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Mayer TU, et al. Science. 1999 Oct 29;286(5441):971-4. 2. Kapoor TM, et al. J Cell Biol. 2000 Sep 4;150(5):975-88. 3. DeBonis S, et al. Biochemistry. 2003 Jan 21;42(2):338-49. 4. Maliga Z, et al. Chem Biol. 2002 Sep;9(9):989-96.
molnova catalog
related products
  • BRD 9876

    BRD 9876 is an ATP- and ADP-competitive Eg5 (kinesin-5) inhibitor with Ki of 4 nM.

  • MK-8267

    MK-8267 (SCH 2047069) is a potent, orally bioavailable, brain penetrant kinesin spindle protein (KSP) inhibitor with EC50 of 3 nM.

  • GSK-923295

    The first potent, allosteric inhibitor of CENP-E kinesin motor ATPase activity with Ki of 3.2 nM.